COlombia DAISe FEasibility Exercise

NCT05631483 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2024-08-09

No results posted yet for this study

Summary

This study is to assess initial safety and performance data of the DAISe Thrombectomy Device for removal of thrombus during an acute ischemic stroke.

Conditions

  • Stroke, Acute Ischemic

Interventions

DEVICE

DAISe

Use of the DAISe Thrombectomy Device

Sponsors & Collaborators

  • MIVI Neuroscience, Inc.

    lead INDUSTRY

Principal Investigators

  • Boris Pabon, MD · Angiosur

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-14
Primary Completion
2023-04-26
Completion
2023-08-02

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05631483 on ClinicalTrials.gov